Xylazine and Overdoses: Trends, Concerns, and Recommendations

Area of Science:

• Public Health
• Toxicology
• Drug Policy

Background:

• Xylazine, a veterinary anesthetic, is a nonopioid drug. It is increasingly detected in the illicit drug supply in the United States. Data show a high prevalence of xylazine in overdose deaths involving opioids.

Purpose of the Study:

• To highlight the growing public health concern of xylazine in the illicit drug supply.
• To emphasize the need for increased testing and research into xylazine's toxicity and prevalence.
• To advocate for public health interventions and harm reduction strategies.

Main Methods:

• The study is a review and analysis of current data on xylazine detection in the illicit drug supply and its association with overdose deaths.
• It examines the limitations of existing testing methods for xylazine.
• It discusses the implications for public health response and harm reduction.

Main Results:

• Xylazine is prevalent among individuals who have died from opioid-involved overdoses.
• There is a significant lack of adequate testing methods to identify xylazine in drug supplies.
• This deficiency hinders public health interventions, harm reduction, and treatment development.

Conclusions:

• The emergence of xylazine in the illicit drug supply presents unknown risks to drug users.
• There is an urgent need for the public health system to increase xylazine testing and research.
• Mitigation strategies and novel treatment approaches are necessary to prevent xylazine-related harms.